Evidence map›Paper›PMID 23214944›Full record

ArticleJournal of medicinal chemistry2013

Peptide-conjugated pterins as inhibitors of ricin toxin A.

Ryota Saito, Jeff M Pruet, Lawrence A Manzano, Karl Jasheway, Arthur F Monzingo, Paul A Wiget, Ishan Kamat, Eric V Anslyn, Jon D Robertus

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. The Search for Antidotes Against Ricin.Mini reviews in medicinal chemistry · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ryota SaitoDepartment of Chemistry, Toho University, 2-2-1 Miyama, Funabashi 274-8510, Japan. anslyn@austin.utexas.edu
Jeff M Pruet
Lawrence A Manzano
Karl Jasheway
Arthur F Monzingo
Paul A Wiget
Ishan Kamat
Eric V Anslyn
Jon D Robertus

Funding

Small molecule inhibitors of ricin and shiga toxinsU01AI075509 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI ROBERTUS, JON D · 2007 to 2011
$3.1M
Howard Hughes Medical InstituteNIAID NIH HHS AI 075509NIAID NIH HHS U01 AI075509
6 · The paper itself

Abstract

Several 7-peptide-substituted pterins were synthesized and tested as competitive active-site inhibitors of ricin toxin A (RTA). Focus began on dipeptide conjugates, and these results further guided the construction of several tripeptide conjugates. The binding of these compounds to RTA was studied via a luminescence-based kinetic assay, as well as through X-ray crystallography. Despite the relatively polar, solvent exposed active site, several hydrophobic interactions, most commonly π-interactions not predicted by modeling programs, were identified in all of the best-performing inhibitors. Nearly all of these compounds provide IC₅₀ values in the low micromolar range.

Indexed as

Chemical Warfare AgentsModels, MolecularBinding, CompetitiveCatalytic DomainCrystallography, X-RayHydrophobic and Hydrophilic InteractionsKineticsLuminescent MeasurementsMolecular StructureOligopeptidesProtein BindingPterinsRicinStructure-Activity RelationshipChemical Warfare AgentsOligopeptidesPterinsRicin

Identifiers

PMID23214944
PMCPMC3552522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.